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Centrosome duplication consists of three distinct
steps: (1) loss of orthogonal configuration and separa-In animal cells, duplication of centrosomes and DNA
tion of the paired centrioles, (2) synthesis of a procentri-is coordinated. Since CDK2/cyclin E triggers initiation
ole next to each preexisting centriole, and (3) elongationof both events, activation of CDK2/cyclin E is thought
of the procentrioles (reviewed in Lange and Gull, 1996).to link these two events. We identified nucleophos-
It has been found that the activation of CDK2/cyclin E ismin (NPM/B23) as a substrate of CDK2/cyclin E in
necessary for initiation of centrosome duplication (bothcentrosome duplication. NPM/B23 associates specifi-
separation of centrioles and procentriole formation)cally with unduplicated centrosomes, and NPM/B23
(Hinchcliffe et al., 1999; Lacey et al., 1999). Moreover,dissociates from centrosomes by CDK2/cyclin E–medi-
constitutive activation of CDK2/cyclin E in cells resultsated phosphorylation. An anti-NPM/B23 antibody,
in uncoupling of initiation of centrosome and DNA dupli-which blocks this phosphorylation, suppresses the ini-
cation (Mussman et al., 2000). In these cells, centro-
tiation of centrosome duplication in vivo. Moreover, somes duplicate immediately after entry into G1, much
expression of a nonphosphorylatable mutant NPM/ before the onset of DNA synthesis, indicating that ini-
B23 in cells effectively blocks centrosome duplication. tiation of centrosome duplication primarily depends on
Thus, NPM/B23 is a target of CDK2/cyclin E in the activation of CDK2/cyclin E, while initiation of DNA
initiation of centrosome duplication. replication requires additional events before being trig-
gered by CDK2/cyclin E. In normal cells, the activation
Introduction of CDK2/cyclin E at late G1 triggers initiation of both
centrosome and DNA duplication, and thus coordinates
The centrosome in animal cells consists of a pair of these two events. Moreover, inhibition of CDK2 by CDK
centrioles (the core structure of the centrosome) and an inhibitors abolishes the ability of CDK2/cyclin E to in-
amorphous pericentriolar region composed of a number duce initiation of centrosome duplication, demonstra-
of different proteins, and acts as a microtubule organiz- ting that the kinase activity of CDK2 is required (Hinch-
ing center (for a recent review, see Lange and Gull, cliffe et al., 1999; Lacey et al., 1999; Matsumoto et al.,
1996). During mitosis, the centrosomes function as spin- 1999). Thus, it is reasonable to predict that certain
dle poles, directing the formation of bipolar mitotic spin- centrosomal protein(s) are phosphorylated by CDK2/
dles and determining the cleavage furrow plane, both cyclin E, and that this phosphorylation event may trigger
of which are essential for accurate chromosome trans- the initiation of centrosome duplication.
mission to daughter cells. Since each daughter cell re- Using isolated centrosomes as substrates, we found
ceives one centrosome upon cytokinesis, it must dupli- that nucleophosmin (NPM/B23) is phosphorylated by
cate prior to the next mitosis, and do so only once. Thus, CDK2/cyclin E. Moreover, NPM/B23 is associated with
centrosome duplication must occur in coordination with unduplicated, but not with duplicated centrosomes, and
other cell cycle events, including DNA synthesis. Indeed, dissociates from centrosomes upon phosphorylation by
duplication of centrioles begins near the G1/S boundary CDK2/cyclin E. Microinjection of anti-NPM/B23 anti-
and centrosome duplication is completed in G2 (Vandre body, which blocks this phosphorylation, suppresses
and Borisy, 1989; Tournier and Bornens, 1994). Abroga- the initiation of centrosome duplication. Moreover, ex-
tion of the regulation that coordinates centrosome and pression of the NPM/B23 deletion mutant, which is un-
DNA duplication will likely increase the frequency of able to be phosphorylated by CDK2/cyclin E, blocks
the initiation of centrosome duplication. These findings
show that dissociation of NPM/B23 from centrosomesk To whom correspondence should be addressed (e-mail: kenji.
fukasawa@uc.edu). by CDK2/cyclin E–mediated phosphorylation plays a key
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Figure 1. Identification of the Centrosomal Protein Specifically Phosphorylated by CDK2/Cyclin E as NPM/B23
(A) Centrosomes isolated by a discontinuous sucrose gradient centrifugation were subjected to two-dimensional (2D) gel electrophoresis,
followed by silver staining.
(B) Isolated centrosomes were tested for the microtubule nucleating activity as described (Mitchison and Kirschner, 1986). After the reaction
with purified bovine brain tubulins, centrosomes were sedimented on coverslips, probed with anti-a-tubulin monoclonal (DM1A) (panel a) and
anti-g-tubulin polyclonal antibodies (panel b), and detected with rhodamine-conjugated goat anti-mouse IgG and FITC-conjugated goat anti-
rabbit IgG antibodies. Scale bar, 10 mm.
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role in the initiation of centrosome (centriole) dupli- closely matched the peptide fingerprint of NCBI entry
2,500,582 (murine nucleophosmin [NPM]/B23), match-cation.
ing 9 of 17 peptide fragments generated within the size
range analyzed (31% protein coverage) (Figure 1D). To
Results verify this putative identity, post source decay (PSD)
analysis was performed on one prominent peptide frag-
Identification of NPM/B23 as a Centrosomal ment (1568.73 m/z, indicated by an arrowhead in Figure
Protein Substrate of CDK2/Cyclin E 1D), and the fragment ions detected were independently
To identify centrosomal protein(s) phosphorylated by searched against the NCBInr database using the MS-
CDK2/cyclin E, we isolated centrosomes from quiescent Tag search algorithm. The 1568.73 Da peptide was iden-
Swiss 3T3 cells by discontinuous sucrose gradient tified as part of NPM/B23 with all 72 fragment ions gener-
fractionation as described previously (Moudjou and ated compatible with its fragmentation (Figure 1E).
Bornens, 1994). The isolated centrosomes were tested
for its purity by two-dimensional (2D) gel electrophore-
sis, followed by silver staining (Figure 1A). The 2D spot NPM/B23 Is Phosphorylated by CDK2/Cyclin E
pattern of the isolated centrosomes was similar to those In Vitro
previously published for highly purified centrosomes To test whether NPM/B23 is a direct substrate of CDK2/
(Moudjou et al., 1996). We also tested the functionality cyclin E, we prepared bacterially purified wild-type (wt)
of the centrosomes by an in vitro microtubule nucleation and several deletion mutant NPM/B23 fused with gluta-
assay (Mitchison and Kirschner, 1984) (Figure 1B). Most thione-S-transferase (GST) (Figure 2A). Using these
of the centrosomes nucleated microtubules, demonstrat- GST-NPM/B23 proteins and purified CDK2/cyclin E, we
ing the functional integrity of the isolated centrosomes. performed an in vitro kinase assay (Figure 2B). GST
Using the isolated centrosomes as substrates, we per- moiety of the protein was not phosphorylated by CDK2/
formed an in vitro kinase assay with purified CDK2/ cyclin E, as no phosphorylation was detected in the
cyclin E in the presence of [g32-P]ATP. As controls, the reaction with GST 1 CDK2/cyclin E (lane 1). CDK2-cyclin
kinase reactions were performed in parallel with either E phosphorylated wt and two deletion mutants (D84–151
centrosomes alone or CDK2/cyclin E alone. The reaction and D14–107), while one deletion mutant (D186–239)
mixtures were subjected to 2D gel electrophoresis (Fig- failed to be phosphorylated. Thus, the CDK2/cyclin
ure 1C). Several distinct spots were observed in the E–mediated phosphorylation site(s) of NPM/B23 is lo-
reaction with the centrosomes alone (Figure 1C, panel cated between amino acid residues 186 and 239. In-
a). This is expected, since isolated centrosomes are deed, sequence analysis of NPM/B23 (Chan et al., 1989)
known to be associated with kinase(s) and display auto- showed the presence of four CDK2 phosphorylation
phosphorylation activity (Keryer et al., 1995). CDK2/ consensus sequences in this region.
cyclin E alone showed several isoelectrically distinct
spots z50 kDa in size (Figure 1C, panel c). These spots
represented autophosphorylated cyclin E (Koff et al., NPM/B23 Associates with Centrosomes
To examine the potential involvement of phosphoryla-1992; Won and Reed, 1996). Like many other kinases,
autophosphorylation of cyclin E occurs at high levels tion of NPM/B23 by CDK2/cyclin E in centrosome dupli-
cation, we first characterized the available anti-NPM/when the potential substrates are absent in the reaction.
Thus, the spots associating with the cyclin E autophos- B23 monoclonal antibody, which was raised against an
entire NPM/B23 protein (Yung et al., 1985). We examinedphorylation (panel c) were less significant in the gel with
centrosome 1 CDK2/cyclin E (panel b). Comparison of whether this antibody detects both phosphorylated and
unphosphorylated NPM/B23. To this end, it was neces-the spot pattern of the reaction (centrosome 1 CDK2/
cyclin E) with those of the controls (panels a and c) sary to separate phosphorylated and nonphosphory-
lated GST-NPM/B23 proteins in SDS-PAGE. In vitro ki-revealed one spot unique to the experimental reaction
(Figure 1C, panel b, indicated by an arrow). To identify nase reactions with GST-NPM/B23 with or without
CDK2/cyclin E in the presence of [g32-P]ATP were runthe protein of this spot, the spot was excised and sub-
jected to in-gel tryptic digestion. The eluted fragments on SDS-PAGE, and blotted on to a membrane. The blot
was subjected to autoradiography as well as immu-were analyzed by MALDI-TOF mass spectrometry. The
peptide mass fingerprint was compared to predicted noblot analysis using anti-NPM/B23 antibody. We found
that the standard pH 8.8 SDS-PAGE did not separatepeptides generated from the NCBInr database by the
MS-Fit search algorithm. The digestion profile most phosphorylated and nonphosphorylated GST-NPM/B23
(C) Centrosomes isolated from quiescent Swiss 3T3 cells were subjected to an in vitro kinase reaction in the presence of [g-32P]ATP without
(panel a) or with CDK2/cyclin E (panel b). Panel c shows a reaction with CDK2/cyclin E alone. The reaction samples were subjected to 2D
electrophoresis and autoradiography. An arrow indicates a spot unique to the reaction sample containing centrosomes 1 CDK2/cyclin E.
(D) Peptide mass fingerprints of the phosphorylated protein unique to the reaction with centrosomes 1 CDK2/cyclin E. A spot in the total of
three 2D gels (Figure 1C, panel b) was excised and subjected to in-gel tryptic digestion. The trypsin-digested peptides were subjected to
MALDI-TOF mass spectrometry analysis and NCBInr database search by the MS-Fit algorithm. Nine ion signals whose measured masses
matched theoretical monoisotopic masses of protonated tryptic peptides of NPM/B23 (NCBI entry 2500582) within 25 ppm are indicated with
their measured masses. The peaks with asterisks are from tryptic autodigestion.
(E) PSD analysis was performed on one prominent peptide fragment (1568.73 m/z, indicated by an arrowhead in [D]). The 72 fragment ions
identified were independently searched against the NCBInr database using the MS-Tag search algorithm, and the 1568.73 Da peptide was
identified as part of NPM/B23 (VDNDENEHQLSLR). All 72 fragment ions generated are compatible with its fragmentation. The b- and y-ion
series represent those which were generated from degradation inward from the N and C termini, respectively. The b- and y-fragment ions
identified in the PSD analysis are indicated by underlined masses.
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Figure 2. CDK2/Cyclin E Phosphorylates NPM/
B23 In Vitro
Wild-type and three deletion mutant NPM/
B23 proteins shown in (A) were fused to GST.
Bacterially expressed GST-NPM/B23 fusion
proteins were subjected to in vitro kinase re-
actions with purified CDK2/cyclin E (B). The
reaction samples were run on 10% SDS-
PAGE (pH 8.8), and autoradiographed (left
panel). The right panel shows the Coomassie
blue–stained gel.
(data not shown). However, a readily detectable separa- NPM/B23 Associates Specifically
with Unduplicated Centrosomestion of phosphorylated and nonphosphorylated GST-
NPM/B23 proteins was achieved when pH 7.4 SDS- We examined whether NPM/B23 was localized to the
centrosome. The exponentially growing Swiss 3T3 cellsPAGE was used (Figure 3A, right panel). The same blot
was probed with anti-NPM/B23 antibody. The antibody were co-immunostained for g-tubulin and NPM/B23. As
shown in the previous studies (Spector et al., 1984; Yungdetected two bands in the reaction with CDK2/cyclin E
and a single band without CDK2/cyclin E (Figure 3A, et al., 1985), NPM/B23 was found primarily in the nucleo-
lus. In addition, we observed colocalization of NPM/B23left panel). Superimposition of the autoradiography and
immunoblot revealed that the faster migrating band and g-tubulin as a co-immunostained dot adjacent to the
nucleus, which is characteristic to centrosome stainingrepresented the phosphorylated GST-NPM/B23. These
studies show that the antibody detected both phosphor- (Figure 4A, panels a–d). However, colocalization of NPM/
B23 and g-tubulin at the centrosome was only detectedylated and unphosphorylated NPM/B23.
We next examined the specificity of this antibody by in cells with one centrosome, but not in interphase cells
with two centrosomes (Figure 4A, panels e–h). Statisticalimmunoblot of the whole-cell lysates from Swiss 3T3
cells, primary mouse embryonic fibroblasts (MEFs), and analysis revealed that not all of the cells with one
centrosome showed localization of NPM/B23 at theprimary adult mouse skin fibroblasts (MSFs). This anti-
body detected a single band of NPM/B23 (z38 kDa) in centrosome: NPM/B23 was found at the centrosome in
z60% of the cells with one centrosome (Figure 4B).all lysates (Figure 3B), demonstrating that this antibody
is highly specific. These results suggest that NPM/B23 may associate with
unduplicated, but not with duplicated centrosomes inWe tested whether NPM/B23 was present in the iso-
lated centrosomes. The centrosomes were isolated from interphase cells, and that NPM/B23 may dissociate from
centrosomes during G1 progression. To test this, wequiescent Swiss 3T3 cells by discontinuous sucrose gra-
dient fractionation. We determined the sucrose gradient first synchronized Swiss 3T3 cells by serum starvation,
followed by serum stimulation. To monitor the cell cyclefraction(s) containing centrosomes by immunoblot anal-
ysis for the presence of g-tubulin, a major component progression after serum stimulation, cells in the parallel
cultures were subjected to a BrdU incorporation assay.of centrosomes (for a review, see Joshi, 1994). The
g-tubulin was present in fractions 2–4 (Figure 3C, bottom At 0, 3, 6, 9, and 12 hr after serum stimulation, cells were
examined for BrdU incorporation by immunostaining ofpanel), in which the level of g-tubulin was maximal in
the fraction 4 corresponding to 55%–60% wt/wt su- incorporated BrdU (Figure 4C). At 6 hr after serum stimu-
lation, virtually no cell showed BrdU incorporation.crose. The fractions were then probed with anti-NPM/
B23 antibody (Figure 3C, top panel). NPM/B23 was pres- Between 6 and 12 hr after serum stimulation, the number
of cells that had incorporated BrdU increased, andent in fractions 2, 3, and 4, and its elution profile paral-
leled that of g-tubulin, suggesting that NPM/B23 associ- z20% of cells were BrdU positive at 12 hr. Cells were
also immunostained with anti-NPM/B23 and anti-g-ates with centrosomes.
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Figure 3. Association of NPM/B23 with the Centrosome
(A) The anti-NPM/B23 monoclonal antibody (Yung et al., 1985) was tested for the ability to detect both phosphorylated and unphosphorylated
NPM/B23. Wild-type GST-NPM/B23 was subjected to an in vitro kinase reaction (left panel) with [g32-P]ATP in the presence (lane 2) and
absence (lane 1) of CDK2/cyclin E. The reaction mixtures were run on 10% SDS-PAGE (pH 7.4) and blotted onto a membrane, which was
autoradiographed (left panel) and probed with anti-NPM/B23 antibody (right panel). The immunoblot analysis detected two differently migrating
bands in the reaction with CDK2/cyclin E. Superimposition of the autoradiography and immunoblot showed that the faster migrating band
corresponded to the phosphorylated form of GST-NPM/B23 (indicated by an asterisk).
(B) The specificity of the anti-NPM/B23 antibody was tested by immunoblotting the cell lysates prepared from Swiss 3T3 cells, primary mouse
embryonic fibroblasts (MEFs), and primary mouse adult skin fibroblasts (MSFs). The left panel shows the Coomassie blue–stained membrane,
which was used for the immunoblot analysis (right panel).
(C) NPM/B23 is specifically detected in the discontinuous sucrose gradient fractions containing centrosomes. Each fraction of the discontinuous
sucrose gradient fractionation was subjected to immunoblot analysis using anti-NPM/B23 monoclonal antibody (upper panel) and anti g-tubulin
polyclonal antibody (lower panel).
tubulin antibodies (Figure 4D). Under a serum-starved reassociates with the centrosomes. Previous study has
shown that NPM/B23 is present at spindle poles duringcondition, .80% of cells contained one centrosome,
and the rest contained two centrosomes. More than mitosis (Zatsepina et al., 1999), indicating that the
centrosomes reacquire NPM/B23 prior to or during mito-90% of the cells with one centrosome showed readily
detectable localization of NPM/B23 at the centrosome, sis. The duplicated centrosomes migrate along the nu-
clear membrane to eventually position orthogonally towhile NPM/B23 was not detected at the centrosomes
in cells with two centrosomes. At 6 hr after serum stimu- each other, which is followed by onset of mitosis. We
thus examined the centrosomal colocalization of NPM/lation, virtually no cells had initiated centrosome dupli-
cation, and NPM/B23 remained associated with the B23 and g-tubulin during this period (Figure 5). NPM/B23
was not detected at the centrosomes during separationcentrosomes. Between 6 and 12 hr, the percent of cells
with one centrosome that showed NPM/B23 at the and migration (panels a–l). However, during mitosis, as-
sociation of NPM/B23 with the mitotic poles (centro-centrosome decreased to z30%. Thus, NPM/B23 ap-
pears to dissociate from centrosomes during G1 pro- somes) was evident (panels m–p), suggesting that
centrosomes reacquire NPM/B23 during mitosis.gression.
To corroborate the immunocytochemical observa-
tions, we isolated centrosomes from cells serum stimu-
lated for 0, 6, and 12 hr by discontinuous sucrose gradi- NPM/B23 Dissociates from Centrosomes by
CDK2/Cyclin E–Mediated Phosphorylationent fractionation. The fractions were examined for the
levels of NPM/B23 by immunoblot analysis (Figure 4E). We tested whether NPM/B23 changes its affinity to
centrosomes upon phosphorylation by CDK2/cyclin E.As a control, the fractions were probed with anti-g-
tubulin antibody. Up to 6 hr after serum stimulation, After in vitro kinase reactions with or without CDK2/
cyclin E using the isolated centrosomes as substrates,NPM/B23 was detected at high levels in the centrosomal
fractions. At 12 hr after serum stimulation, however, the reaction mixtures were separated into the pellet
(containing centrosomes) and the supernatant by cen-the level of NPM/B23 in the centrosomal fractions was
dramatically decreased. These results further support trifugation. The pellet and supernatant were subjected
to immunoblot analysis for NPM/B23. When the centro-the dissociation of NPM/B23 from centrosomes during
G1 progression. somes were incubated with CDK2/cyclin E, the majority
of NPM/B23 was present in the supernatant (Figure 6,We next examined when, in the cell cycle, NPM/B23
Cell
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Figure 4. NPM/B23 Associates Specifically with Unduplicated Centrosomes
(A) Exponentially growing Swiss 3T3 cells were immunostained with anti-g-tubulin polyclonal (a and e, red) and anti-NPM/B23 monoclonal
antibodies (b and f, green). Cells were also counterstained with DAPI (c and g). Panels d and h show the overlay of images shown in panels
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Figure 5. NPM/B23 Reassociates with Cen-
trosomes during Mitosis
Exponentially growing Swiss 3T3 cells were
briefly extracted with 0.75% Triton-X in PBS
prior to fixation, and subjected to co-immu-
nostaining with anti-g-tubulin polyclonal (red,
a, e, i, and m) and anti-NPM/B23 monoclonal
antibodies (green, b, f, j, and n). Cells were
also counterstained with DAPI (c, g, k, and
o). Panels d, h, l, and p show the overlay
images of the g-tubulin and NPM/B23 immu-
nostainings. Arrows indicate centrosomes.
Arrows in panels b, f, j, and n were placed at
the same positions as those in a, e, i, and m,
respectively. Scale bar, 10 mm.
upper panel, lane 4). In contrast, most NPM/B23 re- serum stimulated for 4 hr, and anti-NPM/B23 antibody
was cytoplasmically injected. As a control, cells weremained in the pellet (centrosomes) in the absence of
CDK2/cyclin E (lane 1). As a control, we performed im- injected with anti-gag monoclonal antibody. To identify
the injected cells, FITC-conjugated GST (FITC-GST) wasmunoblot analysis of the same reaction mixtures with
anti-g-tubulin antibody. g-tubulin remained in the pellets included in all of the microinjection experiments. After
culturing the injected cells for an additional 6 hr (hence,(centrosome fractions), and was not detected in the su-
pernatants, regardless of presence or absence of CDK2/ cells were serum stimulated for a total of 10 hr), cells
were examined for centrosomes by g-tubulin immuno-cyclin E, confirming that the supernatants were not con-
taminated with centrosomes (lower panel). These results staining (Figures 7A and 7B). Approximately 40% of cells
microinjected with FITC-GST alone showed anti-g-suggest that NPM/B23 phosphorylated by CDK2/cyclin
E dissociates from centrosomes. tubulin antibody-reactive doublets characteristic of du-
plicated centrosomes (Figure 7B, panel a9, indicated by
arrows). A similar frequency of centrosome duplicationMicroinjection of anti-NPM/B23 Antibody Blocks
was observed in cells randomly selected from unin-the Initiation of Centrosome Duplication
jected cells surrounding the injected cells (Figure 7A).To elucidate the functional role of NPM/B23 in cen-
Thus, microinjection of FITC-GST does not affect thetrosome duplication in vivo, we tested the inhibitory
centrosome duplication process. When the anti-NPM/effect of anti-NPM/B23 antibody on centrosome dupli-
cation by microinjection. Quiescent Swiss 3T3 cells were B23 antibody was injected, centrosome duplication was
a and b, and e and f, respectively. Cells with one (unduplicated) centrosome show the colocalization signals of NPM/B23 and g-tubulin at the
centrosome (a and b, indicated by arrows). In contrast, colocalization of NPM/B23 and g-tubulin was not detected in cells with two centrosomes
(e and f, indicated by arrows). The arrows in panel e point to centrosomes. The arrows in panel f were placed at the same position as those
in panel e. Scale bar, 10 mm.
(B) Statistical analysis of association of NPM/B23 with centrosomes. Number of centrosomes per cell (n 5 1, 2, or $3) were determined by
co-immunostaining of g-tubulin and NPM/B23. A minor population (2%–4%) of Swiss 3T3 cells contained hyperamplified centrosomes (n $
3). For the analysis, .400 cells were examined.
(C) BrdU incorporation kinetics of serum-stimulated Swiss 3T3 cells. Cells were serum starved for 48 hr, followed by serum stimulation with
medium containing 20% FBS and BrdU. At indicated time points, cells were immunostained for incorporated BrdU. BrdU incorporation was
analyzed by fluorescence microscopy.
(D) Immunocytochemical analysis of association of NPM/B23 with centrosomes during G1 progression. Serum-starved Swiss 3T3 cells were
serum stimulated. At indicated time points, cells were co-immunostained for g-tubulin and NPM/B23. For each preparation of cells, .400
cells were examined.
(E) Biochemical analysis of association of NPM/B23 with centrosomes during G1 progression. The cell homogenates derived from serum-
stimulated Swiss 3T3 cells (z2 3 107 cells) described above in (D) were subjected to a discontinuous sucrose gradient fractionation. The
fractions were subjected to immunoblot analysis for NPM/B23 (upper panel of each set) and g-tubulin (lower panel).
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SDS/PAGE and autoradiographed (Figure 7C, a, upper
panel). When the centrosomes were incubated with anti-
gag antibody, the phosphorylated NPM/B23 was ob-
served in the supernatant (lane 2), but not in the pellet
(lane 1). In contrast, with anti-NPM/B23 antibody, phos-
phorylated NPM/B23 was not found in either pellet or
supernatant (lanes 3 and 4). The immunoblot analysis
of the reaction mixtures by anti-NPM/B23 antibody
showed the presence of high levels of NPM/B23 in the
supernatant of the reaction with the control anti-gag
antibody, but not of the reaction with anti-NPM/B23
antibody (Figure 7C, a, lower panel). Thus, binding of
anti-NPM/B23 antibody blocks CDK2/cyclin E–medi-
Figure 6. NPM/B23 Dissociates from Centrosomes by CDK2/Cyclin ated phosphorylation of NPM/B23.
E–Mediated Phosphorylation
To corroborate the above finding, in vitro kinase reac-
Centrosomes isolated from quiescent Swiss 3T3 cells were sub- tions were performed using GST-NPM/B23. GST-NPM/
jected to in vitro kinase reactions with or without CDK2/cyclin E.
B23 (wt) proteins were preincubated with anti-gag, anti-The centrosomes were pelleted by centrifugation, and the pellets
myc, or anti-NPM/B23 antibodies, which was followedand supernatants were analyzed by immunoblot using anti-NPM/
by in vitro kinase reactions with CDK2/cyclin E (FigureB23 (upper panel) or anti-g-tubulin (lower panel) antibodies.
7C, b). GST-NPM/B23 preincubated with either anti-gag
(lane 2) or anti-myc (lane 3) antibody was phosphory-
lated by CDK2/cyclin E at similar levels with the controlinhibited (Figures 7A and 7B, panel c9, indicated by an
with no antibody (lane 1). In contrast, the level of phos-arrowhead), while anti-gag antibody did not show any
phorylation was dramatically decreased in the GST-inhibitory effect on centrosome duplication (Figures 7A
NPM/B23 preincubated with anti-NPM/B23 antibodyand 7B, panel b9, indicated by arrows). When the NPM/
(lane 4). These results show that the phosphorylationB23 antibody was preincubated with GST-NPM/B23
of NPM/B23 by CDK2/cyclin E may be critical for theproteins, anti-NPM/B23 antibody failed to exert an inhib-
dissociation of NPM/B23 from centrosomes, suggestingitory effect on centrosome duplication (Figure 7A). Thus,
that NPM/B23 may be a key target of CDK2/cyclin E inanti-NPM/B23 antibody blocks centrosome duplication
the initiation of centrosome duplication.in vivo, implicating NPM/B23 in the regulation of cen-
trosome duplication.
To eliminate the possibility that the doublets detected Expression of Nonphosphorylatable Mutant
NPM/B23 Blocks Centrosome Duplicationby anti-g-tubulin antibody represent splitting of the cen-
triole pair rather than centrosome duplication, we also We tested whether the deletion mutant NPM/B23
(NPMD186–239) that failed to be phosphorylated byimmunostained the injected cells with anti-a-tubulin an-
tibody in one experiment. Since a-tubulin is one of the CDK2/cyclin E (Figure 2) acts as a dominant-negative
when expressed in cells. The genes encoding wt NPM/major constituents of centrioles, immunostaining of
a-tubulin allows visualization of a centriole pair within B23 and three deletion mutants (NPMD14–107, NPMD84–
151, and NPMD186–239) (see Figure 2A) were FLAGthe centrosome at a high magnification, when cells are
subjected to cold treatment and brief extraction prior to epitope tagged, and transfected into Swiss 3T3 cells
together with a plasmid encoding a puromycin-resistantfixation, which depolymerizes microtubules nucleated
at the centrosomes. Representative immunostaining is gene. As a control, the vector was transfected. The puro-
mycin-resistant cells at 48 hr post-transfection were re-shown in Figure 7B (panels d–d99). Each of the signals
identified as two dots at a low magnification (panel d9) plated and cultured for an additional 48 hr. Cells were
first examined for the expression of transfected NPM/was resolved to a pair of dots at a higher magnification,
representing a centriole pair (panel d, inset). The B23 by immunoblot analysis using anti-FLAG antibody
(Figure 8A). All of the transfectants expressed similarcentrosome duplication frequencies determined by anti-
a-tubulin antibody was similar to those determined by levels of transfected NPM/B23.
Cells were examined for centrosomes by co-immuno-anti-g-tubulin antibody, indicating that the two dots de-
tected by anti-g-tubulin antibody represent duplicated staining of g-tubulin and a-tubulin after cold treatment
and brief extraction (Figure 8B). In the vector-trans-centrosomes.
We next examined how the anti-NPM/B23 antibody fected cells, z40% of cells contained one centrosome
and z60% contained two centrosomes. The cells trans-exerts its inhibitory effect. Two possibilities exist: (1) the
antibody inhibits phosphorylation of NPM/B23 by CDK2/ fected with wt and the two mutants, NPMD14–107 and
NPMD84–151, showed similar profiles in the number ofcyclin E, or (2) the antibody allows the phosphorylation,
but suppresses dissociation of NMP/B23 from centro- centrosomes per cell. In contrast, the majority (.75%) of
cells transfected with the nonphosphorylatable mutant,somes. To test these possibilities, isolated centrosomes
were incubated with anti-NPM/B23 or anti-gag antibodies, NPMD186–239, contained one centrosome, suggesting
that centrosome duplication was blocked by the expres-and were subjected to an in vitro kinase reaction using
purified CDK2/cyclin E in the presence of [g-32P]ATP. The sion of NPMD186–239.
To corroborate these observations, the transfectantsreaction mixtures were centrifuged, and the pellets and
supernatants were heat denatured in the presence of were also examined for the presence of cells with bipolar
mitotic spindles by co-immunostaining with anti-a- and0.5% SDS (see Experimental Procedures). The pellets
and supernatants were then diluted to 0.1% SDS, and b-tubulin monoclonal and anti-g-tubulin polyclonal anti-
bodies (Figure 8C). Approximately 6% of the vector-were subjected to immunoprecipitation using anti-NPM/
B23 antibody. The immunoprecipitates were run on transfected cells had readily identifiable bipolar mitotic
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Figure 7. Microinjection of anti-NPM/B23 Antibody Blocks Initiation of Centrosome Duplication
(A) Quiescent Swiss 3T3 cells were serum stimulated for 4 hr and were microinjected with either anti-NPM/B23 or anti-gag monoclonal
antibody. We also tested anti-NPM/B23 antibody preincubated with GST-NPM/B23. Purified FITC-GST was included as an indicator for injected
cells. Six hours after injection, cells were probed with anti-g-tubulin antibody and detected by rhodamine-conjugated secondary antibody.
Five to fifteen percent of cells contained duplicated centrosomes before microinjection. Thus, prior to each microinjection experiment, we
determined the background level, which was subtracted from the observed centrosome duplication frequencies after microinjection. Aver-
age 6 standard error was determined from three independent experiments. For each experiment, .50 nuclei were examined.
(B) Swiss 3T3 cells were microinjected with FITC-GST plus no antibody (a–a99), plus anti-gag antibody (b–b99), or plus anti-NPM/B23 antibody
(c–c99). Arrows point to duplicated centrosomes, whereas an arrowhead points to an unduplicated centrosome. To determine whether each
dot detected by anti-g-tubulin antibody represents a centriole pair, injected cells in one experiment were immunostained with anti-a-tubulin
antibody. After cold treatment and brief extraction (see Experimental Procedures), injected cells were probed with anti-a-tubulin antibody
(DM1A), and detected by rhodamine-conjugated secondary antibody. Panels d–d99 show the cell injected with FITC-GST 1 anti-gag antibody.
The inset in panel d9 is 43 magnification of the two dots indicated by arrows. Each of the two dots detected at a low magnification is resolved
to a pair of dots. Scale bar, 10 mm.
(C) Anti-NPM/B23 antibody blocks CDK2/cyclin E–mediated phosphorylation.
(a) Centrosomes isolated from quiescent Swiss 3T3 cells were pretreated with anti-gag or anti-NPM/B23 antibody, followed by in vitro kinase
reactions with CDK2/cyclin E in the presence of [g-32P]ATP. After reaction, the centrosomes were pelleted by centrifugation. The pellets and
supernatants were heat denatured in 0.5% SDS for 10 min, diluted to 0.1% SDS, and subjected to immunoprecipitation with anti-NPM/B23
antibody. The immunoprecipitates were run on SDS-PAGE and autoradiographed (upper panel). NPM/B23*: phosphorylated NPM/B23. The
samples were also immunobloted with anti-NPM/B23 antibody (lower panel).
(b) GST-NPM/B23 (wt) was preincubated with no antibody, anti-gag, anti-myc, and anti-NPM/B23 monoclonal antibodies for 15 min at 378C.
The GST-NPM/B23 proteins were then subjected to in vitro kinase reactions with CDK2/cyclin E.
spindles. A similar percentage of cells with bipolar spin- Although the presence of monopolar mitotic cells in
NPMD186–239 transfectants suggests that expressiondles were observed in cells transfected with wt,
NPMD14–107, and NPMD84–151 (representative immu- of NPMD186–239 specifically inhibits centrosome dupli-
cation, it remained to be further clarified whether expres-nostaining of bipolar spindles are shown in Figure 8D,
a–d). Thus, centrosome duplication had occurred in the sion of NPMD186–239 results in general cell cycle arrest
including centrosome duplication, or specific inhibitionwt NPM, NPMD14–107, and NPMD84–151 transfectants.
In contrast, very few cells with bipolar spindles were of centrosome duplication. To test this, Swiss 3T3 cells
were transiently transfected with either a vector ordetected in cells transfected with NPMD186–239. In-
stead, we occasionally observed aberrant mitoses with NPMD186–239 mutant plasmid. The transfected cells
were enriched using a puromycin resistance gene. Themonopolar spindles (Figure 8D, e–h), indicating that
NPMD186–239 transfectants proceeded through the cell puromycin-resistant cells were cultured for an additional
24 hr. During the final 3 hr of culturing, BrdU was addedcycle to mitosis without duplication of centrosomes.
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Figure 8. Expression of the Nonphosphorylatable Mutant NPM/B23 Blocks Centrosome Duplication
(A) Swiss 3T3 cells were transiently transfected with plasmids encoding FLAG epitope–tagged wt and three deletion NPM/B23 mutants
(NPMD186–239, NPMD84–151, and NPMD14–107; see Figure 2). As a control, a vector plasmid was transfected. For each transfection, a
plasmid encoding a puromycin resistant gene (pBabe/puro) was cotransfected as a selection marker. Puromycin was added to medium 24
hr after transfection. At 48 hr after addition of puromycin, puromycin-resistant cells were replated and cultured for an additional 48 hr. The
cell lysates were prepared and probed with anti-FLAG polyclonal antibody.
(B) The transfectants described in (A) were immunostained for centrosomes with anti-g-tubulin polyclonal and anti-a-tubulin monoclonal
antibodies after cold treatment and brief extraction, and detected with FITC-conjugated goat anti-rabbit IgG and rhodamine-conjugated goat
anti-mouse IgG antibodies. The number of centrosomes per cell (n) was statistically analyzed (.400 cells) by fluorescence microscopy.
(C and D) The NPM/B23-transfectants were probed with anti-a-tubulin (DM1A) 1 b-tubulin (Tub. 2.1) monoclonal antibodies and anti-g-
polyclonal antibody, and detected with goat FITC-conjugated anti-mouse IgG and rhodamine-conjugated anti-rabbit IgG antibodies. Cells
were also counterstained with DAPI. Statistical analysis of cells with bipolar mitotic spindles is shown in (C). The results are shown as aver-
age 6 standard error from three experiments. For each transfectant, .300 cells were examined. In the NPMD186–239 transfectants, we
occasionally observed defective mitosis with monopolar spindles (D, panels e–h). Panels a–d show a normal bipolar spindle (wt NPM-
transfectant) as a comparison. Panels a and e, g-tubulin staining (red); panels b and f, a- and b-tubulin staining (green); panels c and g, DAPI
staining. Panels d and h show the overlay image of panels a–c and e–g, respectively. The arrow indicates a spindle pole. Scale bar, 10 mm.
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centrosome duplication is blocked in NPMD186–239-
transfected cells. It should be noted that in NPMD186–
239-transfectants, we observed frequent floating cells
with typical apoptotic phenotypes (i.e., condensed chro-
mosomes). Although the molecular basis of these apo-
ptotic cells is unclear at present, apoptosis may be a
consequence of defective mitosis with monopolar spin-
dles, which is under investigation.
We next asked which duplication stage (splitting of a
centriole pair or synthesis of a procentriole) was blocked
by expression of NPMD186–239 mutant. To this end,
the NPMD186–239-transfected cells were examined by
thin section transmission electron microscopy (Figure
8F, panels a and b show the three dimensional structure
of a centriole pair viewed from different angles). The
centriole pairs in the NPMD186–239-transfected cells
are physically intact with the orthogonal configura-
tion, which is typical of a centriole pair in G1 phase
prior to duplication. Thus, expression of NPMD186–239
does not cause physical disruption of centrioles. More-
over, these observations suggest that expression of
NPMD186–239 results in failure to initiate centrosome
duplication.
The finding that NPM/B23 dissociates from centro-
somes upon CDK2/cyclin E–mediated phosphorylation
implies that the NPMD186–239 mutant associates with
centrosomes. We thus examined the localization of
transfected NPMD186–239 mutant by coimmunostain-
ing with anti-g-tubulin polyclonal and anti-FLAG mono-
clonal antibodies (Figure 9). No anti-FLAG antibody
staining was observed in the vector-transfected cells
(panel b), while anti-FLAG antibody detected single dot
adjacent to nucleus (panel f), which overlaps with the
dot detected by anti-g-tubulin antibody (panels e andFigure 9. NPMD186–239 mutant associates with centrosomes.
h). Thus, NPMD186–239 mutant associates with centro-The vector-transfected (a–d) and NPMD186–239-transfected cells
somes.(e–h) described in the legend to Figure 8 were examined for localiza-
tion of NPMD186–239 mutant by co-immunostaining with anti-g-
tubulin polyclonal (red, a and e) and anti-FLAG monoclonal (green, Discussion
b and f) antibodies. Cells were also counterstained with DAPI (c and
g). Panels d and h show the overlay images of g-tubulin and FLAG
The coordination between the centrosome and DNA du-immunostainings. The arrows in panels a and e point to centro-
plication is at least in part established by CDK2/cyclinsomes. The arrows in panel b were placed at the same position as
E (Hinchcliffe et al., 1999; Lacey et al., 1999). Activatedthose in panel a. Scale bar, 10 mm.
CDK2/cyclin E, which peaks at the G1/S boundary, has
been shown to phosphorylate the Rb protein, releasing
bound E2F transcriptional factor, which stimulates tran-to the media. Cells were coimmunostained with anti-g-
tubulin polyclonal and anti-BrdU monoclonal antibodies scription of genes required for DNA synthesis (reviewed
in Dyson, 1998; Nevins, 1998). Here, we show that NPM/(Figure 8E). Approximately 10% of vector-transfected
and z4% of NPMD186–239-transfected cells were BrdU B23 is a key target of CDK2/cyclin E in the initiation
of centrosome duplication. NPM/B23 associates withpositive, suggesting that the expression of NPMD186–
239 may be partially cytotoxic. Examination of centro- unduplicated, but not with duplicated centrosomes, and
loses its affinity to centrosomes by CDK2/cyclin E–medi-somes revealed that all of the control vector–transfected
BrdU-positive cells contained duplicated centrosomes, ated phosphorylation. The anti-NPM/B23 antibody, which
inhibits CDK2/cyclin E to phosphorylate NPM/B23, re-while the majority (z80%) of NPMD186–239-transfected
BrdU-positive cells contained a single centrosome (Fig- sults in suppression of centrosome duplication. More-
over, expression of the nonphosphorylatable deletionure 8E). These observations further demonstrate that
(E) Swiss 3T3 cells were transiently transfected with either a plasmid encoding FLAG epitope-tagged NPMD186–239 or a vector control. For
each transfection, pBabe/puro was cotransfected as a selection marker. Puromycin was added to medium 16 hr after transfection. Puromycin-
resistant cells at 36 hr after addition of puromycin were replated and further cultured for 24 hr. During the final 3 hr of culturing, BrdU was
added to medium. Cells were then processed for co-immunostaining with anti-BrdU monoclonal and anti-g-tubulin polyclonal antibodies. The
number of centrosomes per cell in the BrdU positive cells was scored by fluorescence microscopy. For each transfectant, .100 BrdU positive
cells were examined.
(F) Electron micrographs of thin sections of the NPMD186–239-transfected cells. The NPMD186–239-transfected cells after puromycin selection
were processed for electron microscopic analysis. Panels a and b show the ultrastructure of the centrosome in two NPMD186–239-transfected
cells. Examination of the adjacent sections showed no other centrosome, indicating these cells containing one centrosome. Scale bar, 0.2 mm.
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bovine serum [FBS], penicillin [100 U/ml], and streptomycin [100 mg/mutant NPM/B23 results in inhibition of centrosome du-
ml]). Transient transfection was performed by the standard calciumplication. Electron microscopic analysis of cells trans-
phosphate method. Cells were transfected with a plasmid encodingfected with this mutant showed that the centriole pair
NPM/B23 together with a puromycin resistance gene plasmidis intact with orthogonal configuration, which is typical
(pBabe/puro) at a molar ratio of 20:1. After incubation for 12 hr atof a preduplication centriole pair in G1 phase. In addition,
378C, the cells were fed with fresh complete medium. The cells were
NPM/B23 is found to associate with the centrosome in fed with fresh complete medium containing puromycin (2 mg/ml)
the subpopulation of cells with one (unduplicated) either 16 or 24 hr after transfection.
centrosome. However, cells with one centrosome bound
by NPM/B23 are enriched in the quiescent and early
Centrosome IsolationG1 phase cell population. As the G1 phase progresses,
Centrosomes were prepared from quiescent Swiss 3T3 cells asNPM/B23 dissociates from centrosomes. All of these
described (Moudjou and Bornens, 1994). After centrifugation by aobservations indicate that NPM/B23 is a target of CDK2/ discontinuous gradient consisting of 500 ml of 70%, 300 ml of 50%,
cyclin E in the initiation of centrosome duplication, and and 300 ml of 40% sucrose solutions, fractions (200 ml/each fraction)
that dissociation of NPM/B23 from centrosomes by were collected from the bottom (fractions 1–7). The aliquots from
CDK2/cyclin E–mediated phosphorylation is a critical each fraction were diluted with 1 ml of PIPES buffer (10 mM PIPES
early step in the centrosome (centriole) duplication pro- [pH 7.2]) and subjected to centrifugation at 15,000 rpm for 10 min.
The fractions that contained centrosomes were determined by im-cess, which presumably occurs when CDK2/cyclin E is
munoblot analysis for g-tubulin. The functional integrity of the iso-activated to a certain threshold level during G1 phase.
lated centrosomes was tested for the microtubule nucleating activityOur finding of NPM/B23 localization at the cen-
as described previously (Mitchison and Kirschner, 1984).trosomes during early-mid G1 phase contrasts with the
previous observation in HeLa cells, in which NPM/B23
is not detected at the centrosomes during interphase In Vitro Kinase Assay
(Zatsepina et al., 1999). Since loss of the regulation of CDK2/cyclin E complexes were purified using a baculovirus expres-
sion system (Desai et al., 1995). Using the purified CDK2/cyclin Ethe centrosome duplication cycle is common in cancer
(300 nM), the isolated centrosomes (50 ng) were subjected to an incells as well as some cell lines established in culture
vitro kinase reaction at 378C for 1 hr in 10 mM PIPES buffer con-(Pihan et al., 1998; Carroll et al., 1999; Mussman et al.,
taining 50 mM cold ATP, 75 mM [g-32P]ATP, 2 mg/ml leupeptin, and2000; M. O. and K. F., unpublished data), centrosome
2 mg/ml aprotinin. For the examination of the inhibitory activity ofduplication may be deregulated in HeLa cells, possibly
anti-NPM/B23-antibody on CDK2/cyclin E–mediated phosphoryla-by the loss of the regulatory role of NPM/B23.
tion, centrosomes were mixed with either anti-NPM/B23 or anti-gag
NPM/B23 is known to be involved in assembly and/ monoclonal antibodies for 30 min prior to the in vitro kinase reaction.
or intranuclear transport of preribosomal particles, and The in vitro kinase reaction was performed as described above
in cytoplasmic/nuclear trafficking (Spector et al., 1984; except for the incubation time of 30 min. The reaction mixture was
Yung et al., 1985; Borer et al., 1989). More recently, NPM/ then separated into the pellet and supernatant by centrifugation.
B23 has been shown to possess molecular chaperoning The pellet was resuspended in 10 mM PIPES buffer containing 0.5%
SDS. To the supernatant, SDS was added to the final concentrationactivities, including preventing protein aggregation, pro-
of 0.5%. The supernatant and pellet were then denatured at 958Ctecting enzymes during thermal denaturation, and facili-
for 10 min and then diluted with the buffer (50mM Tris [pH 8.0] andtating renaturation of chemically denatured proteins
150 mM NaCl) to 0.1% SDS. The samples were then subjected to(Szebeni and Olson, 1999). Since the centrosome con-
immunoprecipitation using anti-NPM/B23 antibody. The immuno-sists of a large number of different proteins, it is interest-
complexes were collected with protein G beads and resolved ining to consider the possibility that the chaperone activity
SDS-PAGE. The gel was dried and autoradiographed. For an assay
of NPM/B23 may be necessary for preventing irrevers- using GST–NPM/B23 fusion proteins as a substrate, the in vitro
ible aggregation within the centrosome proper. More- kinase reaction was performed as described previously (Fukasawa
over, its dissociation from the centrosome may induce et al., 1994).
a dynamic structural change, leading to initiation of
centrosome duplication.
Two-Dimensional ElectrophoresisIn summary, our present study puts forward the fol-
Two-dimensional electrophoresis was performed as describedlowing model of the regulation of centrosome duplica-
(O’Farrell, 1975). In brief, 40 ml of the in vitro kinase reaction sampletion: centrosome-bound NPM/B23 dissociates from
containing 2% SDS, 10% glycerol, and 5% b-mercaptoethanol were
centrosomes upon phosphorylation by CDK2/cyclin E, applied to the anode side of the isoelectric focusing rod gels (diame-
which in turn triggers initiation of centriole duplication. ter 1.5 mm) containing 4% acrylamide, 0.24% bisacrylamide, 9 M
When the nuclear membrane breaks down during mito- urea, a total of 2% w/v carrier ampholytes (pH 5/7: pH 3/10 5 2:1),
sis, most nuclear proteins disperse throughout the and focused within a vertical isoelectric focusing chamber at 11,000
cytoplasm (Nigg, 1988), including NPM/B23, some of Vhr. After focusing, the gels were equilibrated for 5 min in a buffer
containing 125 mM Tris (pH 6.8), 2% SDS, 10% glycerol, 9 mM DTT,which relocalizes to the centrosomes (spindle poles).
and 0.5 mg/ml bromophenol blue, and immediately applied to 10%After mitosis, each daughter cell receives one centro-
SDS-PAGE gel. Electrophoresis was performed for 3 hr at 40 mA. Thesome bound by NPM/B23, which dissociates from the
gels were silver stained, dried, and subjected to autoradiography.centrosome upon exposure to CDK2/cyclin E in the next
cell cycle. In this setting, NPM/B23 would constitute a
licensing system for centrosome duplication, ensuring Mass Spectrometry Analysis
the coordination of centrosome and DNA duplication, The spot from three 2D gels shown by autoradiography was excised,
washed in 25 mM ammonium bicarbonate/50% acetonitrile, driedas well as restricting centrosome duplication to occur
in a vacuum centrifuge, swollen in the digestion buffer containingonce, and only once, within a single cell cycle.
25 mM ammonium bicarbonate and 0.1 mg/ml trypsin, and incubated
at 378C overnight. Peptides were extracted by three changes ofExperimental Procedures
50% acetonitrile/5% trifluoroacetic acid (TFA) and desiccated by
vacuum centrifugation. The dried peptide mixture was dissolved inCells and Transfection
20 ml of 3% TFA, loaded onto the tip of a pulled C18 spherical silicaSwiss 3T3 cells were maintained in complete medium (Dulbecco’s
modified Eagle’s medium [DMEM] supplemented with 10% fetal (ZipTip, Millipore), and washed and eluted with 50% acetonitrile
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containing microcrystalline matrix (a-cyano-4-hydroxy-trans-cin- Acknowledgments
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